Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The evolution of juvenile systemic scleroderma]

M N Starovoĭtova, N G Guseva

    Terapevticheskii Arkhiv
    |January 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Use of "Acellbia"-A Biosimilar of Rituximab in Systemic Sclerosis.

    Doklady. Biochemistry and biophysics·2024
    Same author

    Eight per cent leakage of Lyman continuum photons from a compact, star-forming dwarf galaxy.

    Nature·2016
    Same author

    [Endothelial dysfunction in scleroderma systematica: clinicopathogenetic correlations].

    Terapevticheskii arkhiv·2008
    Same author

    [Overlap syndromes in rheumatology].

    Vestnik Rossiiskoi akademii meditsinskikh nauk·2008
    Same author

    [Significance of bone marrow endothelial progenitor cells in disturbance of angiogenesis and endothelial dysfunction in systemic scleroderma].

    Vestnik Rossiiskoi akademii meditsinskikh nauk·2008
    Same author

    [Unusual case of development of induced scleroderma with general fibrosis, ulcer-necrotic changes in the limbs and calcinosis].

    Terapevticheskii arkhiv·2008
    Same journal

    [History of the Moscow Scientific Society of Cardiology].

    Terapevticheskii arkhiv·2026
    Same journal

    [Antiphospholipid syndrome: ophthalmologic manifestations. A review].

    Terapevticheskii arkhiv·2026
    Same journal

    [Uric acid and mitochondrial dysfunction: a review].

    Terapevticheskii arkhiv·2026
    Same journal

    [Rheumatoid nodule in the myocardium as part of the chain in a clinical detective. Case report].

    Terapevticheskii arkhiv·2026
    Same journal

    [Immunoglobulin G4-related retroperitoneal fibrosis: clinical, laboratory, imaging, and histopathological features in a Russian single-center cohort].

    Terapevticheskii arkhiv·2026
    Same journal

    [Cutaneous manifestations of systemic lupus erythematosus and coexisting dermatologic conditions].

    Terapevticheskii arkhiv·2026
    See all related articles

    Juvenile scleroderma, a childhood autoimmune disease, often has a favorable outcome, with most cases showing slow progression or stabilization. Early detection and treatment significantly improve the prognosis for pediatric scleroderma patients.

    Area of Science:

    • Pediatric Rheumatology
    • Dermatology
    • Autoimmune Diseases

    Background:

    • Scleroderma systemica, particularly in pediatric populations, requires detailed analysis to understand its disease course and prognostic factors.
    • Juvenile-onset systemic sclerosis presents unique challenges in diagnosis and management compared to adult forms.

    Observation:

    • Analysis of 60 cases of juvenile scleroderma revealed a predominantly favorable disease course in 78% of patients.
    • Slow progression was noted in 43%, stabilization in 20%, and complete regression in 15% of cases.
    • Unfavorable outcomes occurred in 5%, with overlap syndrome (17%) indicating an intermediate prognosis.

    Findings:

    • The majority of juvenile scleroderma cases follow a favorable trajectory.
    • Early symptom detection and appropriate therapeutic interventions are critical for improving patient outcomes.

    Related Experiment Videos

  • Overlap syndrome represents a distinct clinical entity with an intermediate prognosis in juvenile systemic sclerosis.

    • Implications:

    • This study highlights the generally optimistic outlook for pediatric scleroderma patients with timely intervention.
    • Findings underscore the importance of early diagnosis and tailored treatment strategies in pediatric rheumatology.
    • Further research into overlap syndrome in juvenile scleroderma may refine management protocols and prognostic assessments.